Literature DB >> 11389689

Highly sensitive and selective fluorescence assays for rapid screening of endothelin-converting enzyme inhibitors.

N Luciani1, H de Rocquigny, S Turcaud, A Romieu, B P Roques.   

Abstract

The highly potent vasoconstrictor peptide endothelin (ET) is generated from an inactive precursor, big endothelin (bET), by endothelin-converting enzyme (ECE). ECE is a phosphoramidon-sensitive zinc metallopeptidase, which is closely related to neprilysin (neutral endopeptidase). It is possible that compounds which inhibit the formation of ET may be used as new drugs for the treatment of cardiovascular diseases. Such an approach requires a fast, simple and selective assay to measure ECE activity, allowing rapid screening of inhibitors. We describe here two new ECE substrates based on the concept of 'intramolecularly quenched fluorescence' which may fulfill this aim. One, S(1) [Pya(21)-Nop(22)-bET-1(19--35)], is the (19--35) fragment of the natural peptide big-ET-1(1--38), which is modified by introducing the fluorescent amino acid, pyrenylalanine (Pya), in position 21 and a quencher, p-nitrophenylalanine (Nop), in position 22. The second substrate (S(2)) is a small peptide, Ac-Ser-Gly-Pya-Lys-Ala-Phe-Ala-Nop-Gly-Lys-NH(2), from a biased substrate peptide library. The recombinant, hECE-1c, cleaved both Pya(21)-Nop(22)-bET-1(19--35) and the natural substrate selectively between residues 21 and 22, whereas cleavage occurred between alanine and phenylalanine in the small peptide. In both cases, this generated intense fluorescence emission. The synthesis and kinetic parameters of these substrates are described. These assays, which can be used directly on tissue homogenates, are the most sensitive and selective described to date for ECE, and are easily automated for a high-throughput screening of inhibitors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389689      PMCID: PMC1221908          DOI: 10.1042/0264-6021:3560813

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Increased plasma endothelin level in patients with essential hypertension.

Authors:  Y Saito; K Nakao; M Mukoyama; H Imura
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

2.  A sandwich-type enzyme immunoassay to detect immunoreactive big-endothelin-1 in plasma.

Authors:  N Suzuki; H Matsumoto; C Kitada; S Kimura; T Miyauchi; M Fujino
Journal:  J Immunol Methods       Date:  1990-03-09       Impact factor: 2.303

3.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

4.  The use of a monoclonal antibody for the rapid purification of kidney neutral endopeptidase ("enkephalinase") solubilized in octyl glucoside.

Authors:  M Aubry; A Berteloot; A Beaumont; B P Roques; P Crine
Journal:  Biochem Cell Biol       Date:  1987-04       Impact factor: 3.626

Review 5.  Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology.

Authors:  B P Roques; F Noble; V Daugé; M C Fournié-Zaluski; A Beaumont
Journal:  Pharmacol Rev       Date:  1993-03       Impact factor: 25.468

6.  A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterization.

Authors:  O Valdenaire; D Lepailleur-Enouf; G Egidy; A Thouard; A Barret; R Vranckx; C Tougard; J B Michel
Journal:  Eur J Biochem       Date:  1999-09

7.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

8.  Intramolecularly-quenched fluorescent peptides as fluorogenic substrates ofleucine aminopeptidase and inhibitors of clostridial aminopeptidase.

Authors:  A Carmel; E Kessler; A Yaron
Journal:  Eur J Biochem       Date:  1977-03-01

9.  Affinity chromatographic purification of angiotensin converting enzyme.

Authors:  M W Pantoliano; B Holmquist; J F Riordan
Journal:  Biochemistry       Date:  1984-02-28       Impact factor: 3.162

10.  The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes.

Authors:  A Inoue; M Yanagisawa; S Kimura; Y Kasuya; T Miyauchi; K Goto; T Masaki
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

View more
  4 in total

1.  Identification of an endothelin-converting enzyme-2-specific fluorigenic substrate and development of an in vitro and ex vivo enzymatic assay.

Authors:  Tanja Ouimet; Sou-Vinh Orng; Hervé Poras; Khatuna Gagnidze; Lakshmi A Devi; Marie-Claude Fournié-Zaluski; Bernard P Roques
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

2.  Detection and quantification of botulinum neurotoxin type a by a novel rapid in vitro fluorimetric assay.

Authors:  Hervé Poras; Tanja Ouimet; Sou-Vinh Orng; Marie-Claude Fournié-Zaluski; Michel R Popoff; Bernard P Roques
Journal:  Appl Environ Microbiol       Date:  2009-05-08       Impact factor: 4.792

3.  Use of activity-based probes to develop high throughput screening assays that can be performed in complex cell extracts.

Authors:  Edgar Deu; Zhimou Yang; Flora Wang; Michael Klemba; Matthew Bogyo
Journal:  PLoS One       Date:  2010-08-05       Impact factor: 3.240

Review 4.  Structure, evolutionary conservation, and functions of angiotensin- and endothelin-converting enzymes.

Authors:  Nathalie Macours; Jeroen Poels; Korneel Hens; Carmen Francis; Roger Huybrechts
Journal:  Int Rev Cytol       Date:  2004
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.